Francisco Javier Ortiz-López

Dr. Francisco Javier Ortiz-López

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
LCLi Chen
Li Chen
QYQun Yue
Qun Yue
XZXinyu Zhang
Xinyu Zhang
MXMeichun Xiang
Meichun Xiang
Chengshu WangChengshu Wang
Chengshu Wang
ZAZhiqiang An
Zhiqiang An
Background: The antifungal therapy caspofungin is a semi-synthetic derivative of pneumocandin B0, a lipohexapeptide produced by the fungusGlarea lozoyensis, and was the first member of the echinocandin class approved for human therapy. The nonribosomal peptide synthetase (NRPS)-polyketide synthases (PKS) gene cluster responsible for pneumocandin biosynthesis fromG. lozoyensishas not been elucidated to date. In this study, we report the elucidation of the pneumocandin biosynthetic gene cluster by whole genome sequencing of theG. lozoyensiswild-type strain ATCC 20868.Results: The pneumocandin biosynthetic gene cluster contains a NRPS (GLNRPS4) and a PKS (GLPKS4) arranged in tandem, two cytochrome P450 monooxygenases, seven other modifying enzymes, and genes for L-homotyrosine biosynthesis, a component of the peptide core. Thus, the pneumocandin biosynthetic gene cluster is significantly more autonomous and organized than that of the recently characterized echinocandin B gene cluster. Disruption mutants of GLNRPS4 and GLPKS4 no longer produced the pneumocandins (A0and B0), and theΔglnrps4andΔglpks4mutants lost antifungal activity against the human pathogenic fungusCandida albicans. In addition to pneumocandins, theG. lozoyensisgenome encodes a rich repertoire of natural product-encoding genes including 24 PKSs, six NRPSs, five PKS-NRPS hybrids, two dimethylallyl tryptophan synthases, and 14 terpene synthases.Conclusions: Characterization of the gene cluster provides a blueprint for engineering new pneumocandin derivatives with improved pharmacological properties. Whole genome estimation of the secondary metabolite-encoding genes fromG. lozoyensisprovides yet another example of the huge potential for drug discovery from natural products from the fungal kingdom.

14 May 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
DCDaniel Carretero‐Molina
Daniel Carretero‐Molina
MSMarina Sánchez-Hidalgo
Marina Sánchez-Hidalgo
JMJesús Martín
Jesús Martín
IGIgnacio González
Ignacio González
OGOlga Genilloud
Olga Genilloud

30 January 2015 in Journal of Natural Products
Verified
Journal Article
Closed access
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
MMMaria Cândida Monteiro
Maria Cândida Monteiro
Gonzalez-Menendez VíctorGonzalez-Menendez Víctor
Gonzalez-Menendez Víctor
Ruben TormoRuben Tormo
Ruben Tormo
OGOlga Genilloud
Olga Genilloud
Fernando ReyesFernando Reyes
Fernando Reyes

13 June 2012 in Journal of Natural Products
Verified
Journal Article
Closed access
Ignacio Pérez-VictoriaIgnacio Pérez-Victoria
Ignacio Pérez-Victoria
JSJesús Martín Serrano
Jesús Martín Serrano
Gonzalez-Menendez VíctorGonzalez-Menendez Víctor
Gonzalez-Menendez Víctor
NPNuria de Pedro
Nuria de Pedro
Noureddine EL AOUADNoureddine EL AOUAD
Noureddine EL AOUAD
Fernando ReyesFernando Reyes
Fernando Reyes

26 December 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Daniel Carretero-MolinaDaniel Carretero-Molina
Daniel Carretero-Molina
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
JSJesús Martín Serrano
Jesús Martín Serrano
DODaniel Oves-Costales
Daniel Oves-Costales
CNCaridad Díaz Navarro
Caridad Díaz Navarro
Fernando ReyesFernando Reyes
Fernando Reyes
As part of our continuing efforts to discover new bioactive compounds from microbial sources, a reinvestigation of extracts of scaled-up cultures of the marine-derived Streptomyces sp. strain CA-271078 resulted in the isolation and structural elucidation of four new napyradiomycins (1–3, 5). The known napyradiomycin SC (4), whose structural details had not been previously described in detail, and another ten related known compounds (6–15). The structures of the new napyradiomycins were characterized by HRMS and 1D- and 2D-NMR spectroscopies and their relative configurations were established through a combination of molecular modelling with nOe and coupling constants NMR analysis. The absolute configuration of each compound is also proposed based on biosynthetic arguments and the comparison of specific rotation data with those of related compounds. Among the new compounds, 1 was determined to be the first non-halogenated member of napyradiomycin A series containing a functionalized prenyl side chain, while 2–4 harbor in their structures the characteristic chloro-cyclohexane ring of the napyradiomycin B series. Remarkably, compound 5 displays an unprecedented 14-membered cyclic ether ring between the prenyl side chain and the chromophore, thus representing the first member of a new class of napyradiomycins that we have designated as napyradiomycin D1. Anti-infective and cytotoxic properties for all isolated compounds were evaluated against a set of pathogenic microorganisms and the HepG2 cell line, respectively. Among the new compounds, napyradiomycin D1 exhibited significant growth-inhibitory activity against methicillin-resistant Staphylococcus aureus, Mycobacterium tuberculosis, and HepG2.

8 April 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
FRFernando Román-Hurtado
Fernando Román-Hurtado
MSMarina Sánchez-Hidalgo
Marina Sánchez-Hidalgo
JSJesús Martín Serrano
Jesús Martín Serrano
FOFrancisco Javier Ortiz-López
Francisco Javier Ortiz-López
OGOlga Genilloud
Olga Genilloud
Cacaoidin is produced by the strain Streptomyces cacaoi CA-170360 and represents the first member of the new lanthidin (class V lanthipeptides) RiPP family. In this work, we describe the complete identification, cloning and heterologous expression of the cacaoidin biosynthetic gene cluster, which shows unique RiPP genes whose functions were not predicted by any bioinformatic tool. We also describe that the cacaoidin pathway is restricted to strains of the subspecies Streptomyces cacaoi subsp. cacaoi found in public genome databases, where we have also identified the presence of other putative class V lanthipeptide pathways. This is the first report on the heterologous production of a class V lanthipeptide.